BMJ  2004;329:34-38 (3 July), doi:10.1136/bmj.329.7456.34

Clinical review

Antidepressants and suicide: what is the balance of benefit and harm

¹ Department of Social Medicine, University of Bristol, Bristol BS8 2PR, ² Wolfson Institute of Preventive Medicine, Barts and the London, Queen Mary's School of Medicine and Dentistry, University of London, London EC1M 6BQ

The first 150 words of the full text of this article appear below.

Introduction

Prescribing of antidepressants has increased greatly in England and elsewhere in recent years.^1-3 This increase has coincided with a fall in rates of suicide, leading some researchers to suggest a causal association.^{2 4-6} Meanwhile, others are concerned that antidepressants may precipitate suicidal behaviour.^{7 8} A recent review of evidence from paediatric trials by the Committee on Safety of Medicines in Britain led to most selective serotonin re-uptake inhibitors (SSRIs) being contraindicated in people aged younger than 18.⁹ So how safe are they? In this article, we assess the data on the risks and benefits.

Is increased prescribing linked to reduced suicide rates?

SSRIs and tricyclic antidepressants account for over 90% of antidepressant prescribing in Britain. Systematic reviews confirm that both these classes of antidepressant are effective in adults,¹⁰ although SSRIs are better tolerated by patients.¹¹ The effectiveness of antidepressants in childhood and adolescence is less clear.¹²

As depression is the main psychiatric condition leading to suicide, it seems reasonable to . . . [Full text of this article]

Time trends

Toxicity

Do antidepressants increase the risk of suicide?

Modelling the effect

Conclusions

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study

Benedict W Wheeler, David Gunnell, Chris Metcalfe, Peter Stephens, and Richard M Martin
BMJ 2008 336: 542-545. [Abstract] [Full Text] [PDF]

Suicide rates in young men in England and Wales in the 21st century: time trend study

Lucy Biddle, Anita Brock, Sara T Brookes, and David Gunnell
BMJ 2008 336: 539-542. [Abstract] [Full Text] [PDF]

Opportunity cost of antidepressant prescribing in England: analysis of routine data

Sandra Hollinghurst, David Kessler, Tim J Peters, and David Gunnell
BMJ 2005 330: 999-1000. [Full Text] [PDF]

Antidepressants and suicide: Rising prescription rate does not mean rising rate of new users

Graham Aldred and David Healy
BMJ 2004 329: 461. [Extract] [Full Text]

Antidepressants and suicide: Risk of completed suicide is not the same as risk of deliberate self harm

Alex J Mitchell
BMJ 2004 329: 461. [Extract] [Full Text]

Do antidepressants reduce suicide?
BMJ 2004 329: 0. [Full Text] [PDF]

This article has been cited by other articles:

• Wheeler, B. W, Gunnell, D., Metcalfe, C., Stephens, P., Martin, R. M (2008). The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study. BMJ 336: 542-545 [Abstract] [Full text]  
• Biddle, L., Brock, A., Brookes, S. T, Gunnell, D. (2008). Suicide rates in young men in England and Wales in the 21st century: time trend study. BMJ 336: 539-542 [Abstract] [Full text]  
• Morgan, O., Griffiths, C., Majeed, A. (2008). Antidepressant prescribing and changes in antidepressant poisoning mortality and suicide in England, 1993-2004. J Public Health (Oxf) 30: 60-68 [Abstract] [Full text]  
• Reseland, S., Bray, I., Gunnell, D. (2007). Author's reply:. Br. J. Psychiatry 190: 79-80 [Full text]  
• DUBICKA, B., HADLEY, S., ROBERTS, C. (2006). Suicidal behaviour in youths with depression treated with new-generation antidepressants: Meta-analysis. Br. J. Psychiatry 189: 393-398 [Abstract] [Full text]  
• Juurlink, D. N., Mamdani, M. M., Kopp, A., Redelmeier, D. A. (2006). The Risk of Suicide With Selective Serotonin Reuptake Inhibitors in the Elderly. Am. J. Psychiatry 163: 813-821 [Abstract] [Full text]  
• RESELAND, S., BRAY, I., GUNNELL, D. (2006). Relationship between antidepressant sales and secular trends in suicide rates in the Nordic countries. Br. J. Psychiatry 188: 354-358 [Abstract] [Full text]  
• Hollinghurst, S., Kessler, D., Peters, T. J, Gunnell, D. (2005). Opportunity cost of antidepressant prescribing in England: analysis of routine data. BMJ 330: 999-1000 [Full text]  
• Gunnell, D., Saperia, J., Ashby, D. (2005). Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ 330: 385- [Abstract] [Full text]  
• Martinez, C., Rietbrock, S., Wise, L., Ashby, D., Chick, J., Moseley, J., Evans, S., Gunnell, D. (2005). Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ 330: 389- [Abstract] [Full text]  
• Geddes, J. R, Cipriani, A. (2004). Selective serotonin reuptake inhibitors. BMJ 329: 809-810 [Full text]  
• Aldred, G., Healy, D. (2004). Antidepressants and suicide: Rising prescription rate does not mean rising rate of new users. BMJ 329: 461-461 [Full text]  
• Mitchell, A. J (2004). Antidepressants and suicide: Risk of completed suicide is not the same as risk of deliberate self harm. BMJ 329: 461-461 [Full text]  

Rapid Responses:

Read all Rapid Responses

Do antidepressants reduce suicide? Ignoring the orphan lithium..

Neil D Burman
bmj.com, 4 Jul 2004 [Full text]

Risk of Completed Suicide is not the same as Risk of Deliberate Self-Harm

Alex J Mitchell
bmj.com, 4 Jul 2004 [Full text]

Typing correction

AJ Mitchell
bmj.com, 14 Jul 2004 [Full text]

Letter of response to the article by D Gunnell and D Ashby

David Healy, et al.
bmj.com, 14 Jul 2004 [Full text]

Antidepressants and suicide in Ireland

Dermot Walsh
bmj.com, 21 Jul 2004 [Full text]

Genetic polymorphisms in CYP2D6 may be the cause of any increased suicidality

Robert Eli
bmj.com, 6 Apr 2006 [Full text]